Women who don't have BRCA mutations could have other high-risk genes that affect treatment choices
This news article has expired. Below you will find a short description about the news article and comments that were left by CancerCompass users.
Researchers found screening, treatments weren't as good as patients with private insurance
Sat Jun 07, 2014 08:53 AM
This fails to say that many are denied access to better chemo drugs because medicare or medicade will not cover them. My personal experience was that people who do not have good insurance and credit do not get Erbitux. The hospital refused to start chemo until they were satisified with my insurance and ability to pay. I went from good insurance to medicare and see a definate difference in care I now receive. Appointments with the hospitals pain management clinic stopped because they do not take medicare patients.
We care about your feedback. Let us know how we can improve your CancerCompass experience.